These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6914810)

  • 1. Effect of trimethoprim or trimethoprim/sulphamethoxazole usage on the emergence of trimethoprim resistance in urinary tract pathogens.
    Dornbusch K; Toivanen P
    Scand J Infect Dis; 1981; 13(3):203-10. PubMed ID: 6914810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trimethoprim alone in the treatment of urinary tract infections: eight years of experience in Finland.
    Kasanen A; Sundquist H
    Rev Infect Dis; 1982; 4(2):358-65. PubMed ID: 7051235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In vitro synergy between sulfamethoxazole and trimethoprim on strains of Staphylococcus aureus sensitive and resistant to methicillin].
    Bismuth R; Jarlier V; Grosset J
    Pathol Biol (Paris); 1983 May; 31(5):429-33. PubMed ID: 6353335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transferable trimethoprim resistance in urinary tract pathogens isolated in Finland and Sweden.
    Dornbusch K; Hagelberg A
    Scand J Infect Dis; 1983; 15(3):285-91. PubMed ID: 6316480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bactericidal activity "in vitro" of sulfamethoxazol-tri-methoprime (SMZ-TMP) alone and in combination with various antibiotics on bacterial strains isolated from urinary tract infections (author's transl)].
    Joly B; Chanal M; Sirot D; Cluzel R; Jouan JP
    Pathol Biol (Paris); 1979 Feb; 27(2):117-24. PubMed ID: 382045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trimethoprim resistance in hospitals.
    Huovinen P; Mäntyjärvi R; Toivanen P
    Br Med J (Clin Res Ed); 1982 Mar; 284(6318):782-4. PubMed ID: 6802226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Rapid method for microbial resistance testing in urinary tract infections?].
    Hotz R; Binswanger U
    Schweiz Med Wochenschr; 1972 Nov; 102(45):1656-9. PubMed ID: 4486570
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro additive effect of nitrofurantoin combined with trimethoprim-sulfamethoxazole against Serratia marcescens.
    Traub WH; Fukushima PI
    Chemotherapy; 1979; 25(3):140-6. PubMed ID: 378572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro susceptibility of Haemophilus influenzae to trimethoprim-sulfamethoxazole.
    Kirven LA; Thornsberry C
    Antimicrob Agents Chemother; 1974 Dec; 6(6):869-70. PubMed ID: 4548834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transferable trimethoprim resistance in three Finnish hospitals.
    Huovinen P; Pulkkinen L; Toivanen P
    J Antimicrob Chemother; 1983 Sep; 12(3):249-56. PubMed ID: 6630108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trimethoprim resistance in Finland after five years' use of plain trimethoprim.
    Huovinen P; Toivanen P
    Br Med J; 1980 Jan; 280(6207):72-4. PubMed ID: 7353129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy of antimicrobial-resistant typhoid fever.
    Butler T; Linh NN; Arnold K; Adickman MD; Chau DM; Muoi MM
    Antimicrob Agents Chemother; 1977 Apr; 11(4):645-50. PubMed ID: 324398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind comparison of sulphonamide-trimethoprim combinations in acute uncomplicated urinary tract infections.
    Skjerven O; Bergan T
    Infection; 1979; 7 Suppl 4():S398-400. PubMed ID: 389813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergence of highly trimethoprim-sulfamethoxazole-resistant Shigella in a native American population: an epidemiologic study.
    Griffin PM; Tauxe RV; Redd SC; Puhr ND; Hargrett-Bean N; Blake PA
    Am J Epidemiol; 1989 May; 129(5):1042-51. PubMed ID: 2650535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trimethoprim-resistant Enterobacteriaceae in urinary tract infection.
    Wong CK; Harding GK; Ronald AR; Hoban S
    Can Med Assoc J; 1975 Jun; 112(13 Spec No):54-8. PubMed ID: 1093652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative activity of sulfamethoxazole-trimethoprim (SMZ-TMP) on bacteria responsible for ORL infections].
    Joly B; Sirot D; Cluzel M; Chanal M; Bruneau D
    Pathol Biol (Paris); 1984 Jun; 32(6):689-92. PubMed ID: 6611536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The emergence and mechanisms of trimethoprim resistance in Escherichia coli isolated from outpatients in Finland.
    Heikkilä E; Renkonen OV; Sunila R; Uurasmaa P; Huovinen P
    J Antimicrob Chemother; 1990 Feb; 25(2):275-83. PubMed ID: 2184160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trimethoprim resistance of Escherichia coli in outpatients in Finland after ten years' use of plain trimethoprim.
    Huovinen P; Renkonen OV; Pulkkinen L; Sunila R; Grönroos P; Klossner ML; Virtanen S; Toivanen P
    J Antimicrob Chemother; 1985 Oct; 16(4):435-41. PubMed ID: 2999058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of trimethoprim and sulfamethoxazole against the nontuberculous mycobacteria.
    Wallace RJ; Wiss K; Bushby MB; Hollowell DC
    Rev Infect Dis; 1982; 4(2):326-31. PubMed ID: 7111959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trimethoprim alone for treatment of urinary tract infection.
    Neu HC
    Rev Infect Dis; 1982; 4(2):366-71. PubMed ID: 7051236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.